Jazz Pharmaceuticals is a specialty pharma company that fits the investment pattern of "high uncertainty with low risk." ...

Though the strategic shift allows pharma to offer integrated health solutions, diversify revenue and improve patient outcomes ...

Shares of EyePoint Pharmaceuticals (EYPT ... comprises nine short-term price targets ranging from a low of $18 to a high of $68, with a standard deviation of $15.13. While the lowest estimate ...

In a remarkable display of market confidence, Collegium Pharmaceutical (NASDAQ:COLL) Inc. shares soared to an all-time high, reaching a price level of $41.04. This milestone ...

RALEIGH, N.C., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals ... including if you: have high blood pressure or are treated for high blood pressure; have a history of diabetes; have ...

The ASX hit a record high, driven by gains in tech, energy, and gold stocks. TechnologyOne shares soar after strong earnings ...

EMERYVILLE, Calif., November 15, 2024--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) ("NovaBay" or the "Company") announces that the largest institutional ...

Phathom Pharmaceuticals, Inc., biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

A local researcher and seasoned executives founded a company that will bring new medical technology to market.